Researchers at Texas A&M University have developed a two-dose nasal spray using extracellular vesicles to reverse neuroinflammation, reduce aging markers, and restore memory in animal models. Published in the Journal of Extracellular Vesicles, the findings highlight a novel approach to treating cognitive decline without invasive procedures.
Inside the Texas A&M Nasal Spray Breakthrough Against Brain Aging
For decades, scientific consensus treated the steady cognitive decline of aging as an inevitable physiological tax. Researchers call this slow burn neuroinflammaging,
a persistent state of low-grade inflammation that smolders inside the brain’s memory centers and increases vulnerability to neurodegenerative disorders like Alzheimer’s disease. A team at the Texas A&M University Naresh K. Vashisht College of Medicine published a landmark study in the Journal of Extracellular Vesicles demonstrating that this inflammatory tide may be reversible through a non-invasive treatment.
Led by Dr. Ashok Shetty alongside senior research scientists Dr. Madhu Leelavathi Narayana and Dr. Maheedhar Kodali, the team engineered an intranasal therapy utilizing microscopic biological parcels called extracellular vesicles. These vesicles act as delivery trucks, bypassing the blood-brain barrier to carry genetic cargo directly into cerebral tissue. According to the research team, intranasal delivery allows direct treatment of the brain without the risks associated with surgery or long-term medication regimens.
Recharging Neuronal Power Plants and Suppressing Inflammation
Once absorbed by the brain’s resident immune cells, the microscopic cargo targets the specific systems driving chronic neuroinflammation. At the same time, the treatment revitalizes neuronal mitochondria, restoring the cellular energy production that falters as the brain ages.
“We are giving neurons their spark back by reducing oxidative stress and reactivating the brain’s mitochondria.”
Dr. Madhu Leelavathi Narayana, Texas A&M University
Behavioral evaluations demonstrated clear functional recovery following the treatment. Animal models treated with the two-dose spray showed significant improvements in recognizing familiar objects, detecting environmental changes, and forming new memories compared to control groups. Furthermore, the therapeutic outcomes proved consistent across both male and female subjects, a uniform response that remains rare in preclinical biomedical studies.
Connecting Lipid Disruption and Neuroimmune Signaling in Alzheimer’s Disease
While the Texas A&M team focused on extracellular vesicles, parallel research highlights how concurrent systemic failures drive neurodegeneration.
Working alongside other institutional researchers, Sijia He and Xianlin Han discovered that sulfatide depletion directly overactivates brain cells known as astrocytes, triggering damaging neurological changes independently of traditional immune triggers. Additional investigations into peripheral immunity, outlined in a perspective published in Cell, emphasize that bidirectional communication between the central nervous system and peripheral immune compartments heavily dictates whether microglial cells adopt protective or destructive programs.
Future Implications for Dementia and Clinical Translation
With new dementia cases in the United States projected to climb sharply over the coming decades—rising from roughly 514,000 cases in 2020 to an estimated 1 million by 2060—researchers emphasize an urgent need for innovative intervention strategies.
Although further preclinical validation is required before human trials begin, the prospect of an accessible nasal spray offers a fundamental shift in how medicine approaches cognitive aging. Investigators hope the strategy could eventually assist stroke recovery and protect aging populations from severe cognitive decline.
“Our approach redefines what it means to grow old. We’re aiming for successful brain aging: keeping people engaged, alert and connected. Not just living longer, but living smarter and healthier.”
Dr. Ashok Shetty, Texas A&M University
Through continued research and development, the team aims to transform this promising laboratory discovery into a practical therapeutic option for everyday clinical use.
Продолжение темы
